<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-03220867</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-25T23:09:56+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study</title>
            <title xml:lang="en" type="sub">TANDEM Study</title>
            <author role="aut">
              <persName>
                <forename type="first">Pascal</forename>
                <surname>Hilliquin</surname>
              </persName>
              <idno type="halauthorid">711303-0</idno>
              <affiliation ref="#struct-184952"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Thomas</forename>
                <surname>Barnetche</surname>
              </persName>
              <idno type="idhal" notation="numeric">772711</idno>
              <idno type="halauthorid" notation="string">872552-772711</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-0975-8534</idno>
              <affiliation ref="#struct-300122"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Athan</forename>
                <surname>Baillet</surname>
              </persName>
              <email type="md5">0cffc95d2c97fab457882f19fe1f9524</email>
              <email type="domain">chu-grenoble.fr</email>
              <idno type="idhal" notation="numeric">1423133</idno>
              <idno type="halauthorid" notation="string">392119-1423133</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-6006-2519</idno>
              <idno type="IDREF">https://www.idref.fr/154950963</idno>
              <idno type="ISNI">http://isni.org/isni/0000000359053185</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/DTF-2298-2022</idno>
              <idno type="VIAF">https://viaf.org/viaf/215337894</idno>
              <affiliation ref="#struct-257328"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">René-Marc</forename>
                <surname>Flipo</surname>
              </persName>
              <email type="md5">a04805f896928e92e938cebbf3fb9203</email>
              <email type="domain">chru-lille.fr</email>
              <idno type="idhal" notation="numeric">1434810</idno>
              <idno type="halauthorid" notation="string">158425-1434810</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-5528-8070</idno>
              <affiliation ref="#struct-425779"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Eric</forename>
                <surname>Lespessailles</surname>
              </persName>
              <email type="md5">f0eba7357e0850f3ba83b3110f5ed69d</email>
              <email type="domain">chr-orleans.fr</email>
              <idno type="idhal" notation="numeric">917197</idno>
              <idno type="halauthorid" notation="string">607358-917197</idno>
              <affiliation ref="#struct-300639"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Christian</forename>
                <surname>Roux</surname>
              </persName>
              <idno type="idhal" notation="numeric">756832</idno>
              <idno type="halauthorid" notation="string">158357-756832</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-5880-2933</idno>
              <affiliation ref="#struct-300113"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Patrice</forename>
                <surname>Fardellone</surname>
              </persName>
              <email type="md5">6c91b9cf7e92189eda581af46ae268e3</email>
              <email type="domain">chu-amiens.fr</email>
              <idno type="idhal" notation="numeric">1032821</idno>
              <idno type="halauthorid" notation="string">159634-1032821</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-3535-3060</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/DWT-4546-2022</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/CNZ-0413-2022</idno>
              <idno type="IDREF">https://www.idref.fr/06972833X</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/DWT-4546-2022</idno>
              <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/CNZ-0413-2022</idno>
              <affiliation ref="#struct-300535"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Anika</forename>
                <surname>Gilbert-Marceau</surname>
              </persName>
              <idno type="halauthorid">2204178-0</idno>
              <affiliation ref="#struct-493731"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Isabelle</forename>
                <surname>Idier</surname>
              </persName>
              <idno type="halauthorid">1279582-0</idno>
              <affiliation ref="#struct-523983"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Arnaud</forename>
                <surname>Constantin</surname>
              </persName>
              <email type="md5">823c462732aa3600566d4266c0428f59</email>
              <email type="domain">univ-tlse3.fr</email>
              <idno type="idhal" notation="numeric">1290743</idno>
              <idno type="halauthorid" notation="string">1031499-1290743</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-2618-2888</idno>
              <affiliation ref="#struct-181247"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Emilie</forename>
                <surname>Shipley</surname>
              </persName>
              <idno type="halauthorid">950810-0</idno>
              <affiliation ref="#struct-1075487"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Guy</forename>
                <surname>Baudens</surname>
              </persName>
              <idno type="halauthorid">1599532-0</idno>
              <affiliation ref="#struct-556696"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Alain</forename>
                <surname>Saraux</surname>
              </persName>
              <email type="md5">0b0d95a2d546f3a0dc96aebde7456fb5</email>
              <email type="domain">univ-brest.fr</email>
              <idno type="idhal" notation="numeric">762362</idno>
              <idno type="halauthorid" notation="string">448066-762362</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-8454-7067</idno>
              <affiliation ref="#struct-412239"/>
              <affiliation ref="#struct-486351"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Athan</forename>
                <surname>Baillet</surname>
              </persName>
              <email type="md5">0cffc95d2c97fab457882f19fe1f9524</email>
              <email type="domain">chu-grenoble.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2024-12-09 15:46:01</date>
              <date type="whenModified">2026-04-29 09:50:02</date>
              <date type="whenReleased">2024-12-09 16:16:23</date>
              <date type="whenProduced">2021-03</date>
              <date type="whenEndEmbargoed">2024-12-09</date>
              <ref type="file" target="https://hal.science/hal-03220867v1/document">
                <date notBefore="2024-12-09"/>
              </ref>
              <ref type="file" subtype="publisherPaid" n="1" target="https://hal.science/hal-03220867v1/file/main.pdf" id="file-4827452-4203821">
                <date notBefore="2024-12-09"/>
              </ref>
              <ref type="externalLink" target="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991027"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="164550">
                <persName>
                  <forename>Athan</forename>
                  <surname>Baillet</surname>
                </persName>
                <email type="md5">0cffc95d2c97fab457882f19fe1f9524</email>
                <email type="domain">chu-grenoble.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-03220867</idno>
            <idno type="halUri">https://hal.science/hal-03220867</idno>
            <idno type="halBibtex">hilliquin:hal-03220867</idno>
            <idno type="halRefHtml">&lt;i&gt;Rheumatology and Therapy&lt;/i&gt;, 2021, 8 (1), pp.95-108. &lt;a target="_blank" href="https://dx.doi.org/10.1007/s40744-020-00253-0"&gt;&amp;#x27E8;10.1007/s40744-020-00253-0&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Rheumatology and Therapy, 2021, 8 (1), pp.95-108. &amp;#x27E8;10.1007/s40744-020-00253-0&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://about.hal.science/hal-authorisation-v1/">HAL Authorization<ref corresp="#file-4827452-4203821"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="UNIV-BREST">Université de Bretagne occidentale - Brest (UBO)</idno>
            <idno type="stamp" n="TIMC-IMAG">TIMC</idno>
            <idno type="stamp" n="IMMUNO" corresp="UNIV-BREST">Lymphocyte B et Auto-immunité, UMR 1227</idno>
            <idno type="stamp" n="IBSAM" corresp="UNIV-BREST">Institut Brestois Santé Agro Matière</idno>
            <idno type="stamp" n="INFINITY">Infinity</idno>
            <idno type="stamp" n="U-PICARDIE">Université de Picardie Jules Verne</idno>
            <idno type="stamp" n="MP3CV" corresp="U-PICARDIE">Mécanismes physiopathologiques et conséquences des calcifications vasculaires - UR UPJV 7517</idno>
            <idno type="stamp" n="TIMC-GREPI" corresp="TIMC-IMAG">T-RAIG : Translationnal Research in Autoimmunity and Inflammation Group</idno>
            <idno type="stamp" n="NANTES-UNIVERSITE">Nantes Université</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study</title>
                <title xml:lang="en" type="sub">TANDEM Study</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Pascal</forename>
                    <surname>Hilliquin</surname>
                  </persName>
                  <idno type="halauthorid">711303-0</idno>
                  <affiliation ref="#struct-184952"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Thomas</forename>
                    <surname>Barnetche</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">772711</idno>
                  <idno type="halauthorid" notation="string">872552-772711</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-0975-8534</idno>
                  <affiliation ref="#struct-300122"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Athan</forename>
                    <surname>Baillet</surname>
                  </persName>
                  <email type="md5">0cffc95d2c97fab457882f19fe1f9524</email>
                  <email type="domain">chu-grenoble.fr</email>
                  <idno type="idhal" notation="numeric">1423133</idno>
                  <idno type="halauthorid" notation="string">392119-1423133</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-6006-2519</idno>
                  <idno type="IDREF">https://www.idref.fr/154950963</idno>
                  <idno type="ISNI">http://isni.org/isni/0000000359053185</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/DTF-2298-2022</idno>
                  <idno type="VIAF">https://viaf.org/viaf/215337894</idno>
                  <affiliation ref="#struct-257328"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">René-Marc</forename>
                    <surname>Flipo</surname>
                  </persName>
                  <email type="md5">a04805f896928e92e938cebbf3fb9203</email>
                  <email type="domain">chru-lille.fr</email>
                  <idno type="idhal" notation="numeric">1434810</idno>
                  <idno type="halauthorid" notation="string">158425-1434810</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-5528-8070</idno>
                  <affiliation ref="#struct-425779"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Eric</forename>
                    <surname>Lespessailles</surname>
                  </persName>
                  <email type="md5">f0eba7357e0850f3ba83b3110f5ed69d</email>
                  <email type="domain">chr-orleans.fr</email>
                  <idno type="idhal" notation="numeric">917197</idno>
                  <idno type="halauthorid" notation="string">607358-917197</idno>
                  <affiliation ref="#struct-300639"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Christian</forename>
                    <surname>Roux</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">756832</idno>
                  <idno type="halauthorid" notation="string">158357-756832</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-5880-2933</idno>
                  <affiliation ref="#struct-300113"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Patrice</forename>
                    <surname>Fardellone</surname>
                  </persName>
                  <email type="md5">6c91b9cf7e92189eda581af46ae268e3</email>
                  <email type="domain">chu-amiens.fr</email>
                  <idno type="idhal" notation="numeric">1032821</idno>
                  <idno type="halauthorid" notation="string">159634-1032821</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-3535-3060</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/DWT-4546-2022</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/CNZ-0413-2022</idno>
                  <idno type="IDREF">https://www.idref.fr/06972833X</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/DWT-4546-2022</idno>
                  <idno type="RESEARCHERID">http://www.researcherid.com/rid/http://www.researcherid.com/rid/CNZ-0413-2022</idno>
                  <affiliation ref="#struct-300535"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Anika</forename>
                    <surname>Gilbert-Marceau</surname>
                  </persName>
                  <idno type="halauthorid">2204178-0</idno>
                  <affiliation ref="#struct-493731"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Isabelle</forename>
                    <surname>Idier</surname>
                  </persName>
                  <idno type="halauthorid">1279582-0</idno>
                  <affiliation ref="#struct-523983"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Arnaud</forename>
                    <surname>Constantin</surname>
                  </persName>
                  <email type="md5">823c462732aa3600566d4266c0428f59</email>
                  <email type="domain">univ-tlse3.fr</email>
                  <idno type="idhal" notation="numeric">1290743</idno>
                  <idno type="halauthorid" notation="string">1031499-1290743</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-2618-2888</idno>
                  <affiliation ref="#struct-181247"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Emilie</forename>
                    <surname>Shipley</surname>
                  </persName>
                  <idno type="halauthorid">950810-0</idno>
                  <affiliation ref="#struct-1075487"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Guy</forename>
                    <surname>Baudens</surname>
                  </persName>
                  <idno type="halauthorid">1599532-0</idno>
                  <affiliation ref="#struct-556696"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Alain</forename>
                    <surname>Saraux</surname>
                  </persName>
                  <email type="md5">0b0d95a2d546f3a0dc96aebde7456fb5</email>
                  <email type="domain">univ-brest.fr</email>
                  <idno type="idhal" notation="numeric">762362</idno>
                  <idno type="halauthorid" notation="string">448066-762362</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-8454-7067</idno>
                  <affiliation ref="#struct-412239"/>
                  <affiliation ref="#struct-486351"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">117594</idno>
                <idno type="issn">2198-6576</idno>
                <idno type="eissn">2198-6584</idno>
                <title level="j">Rheumatology and Therapy</title>
                <imprint>
                  <publisher>Springer</publisher>
                  <biblScope unit="volume">8</biblScope>
                  <biblScope unit="issue">1</biblScope>
                  <biblScope unit="pp">95-108</biblScope>
                  <date type="datePub">2021-03</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1007/s40744-020-00253-0</idno>
              <idno type="pubmed">33216287</idno>
              <idno type="pubmedcentral">PMC7991027</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">Tocilizumab</term>
                <term xml:lang="en">Rheumatoid arthritis</term>
                <term xml:lang="en">Disease-modifying antirheumatic drugs</term>
                <term xml:lang="en">Biological therapy</term>
                <term xml:lang="en">Tocilizumab</term>
              </keywords>
              <classCode scheme="halDomain" n="sdv.mhep.rsoa">Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system</classCode>
              <classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Introduction: Drug retention is particularly relevant to assess long-term treatments. This real-world study mainly aimed to describe 1-year retention rate (RR) of subcutaneously administered tocilizumab (TCZ-SC) in patients with moderate to severe active rheumatoid arthritis (RA).Methods: This non-interventional, prospective, multicenter study (NCT02608112) was conducted in patients with RA initiating TCZ-SC treatment, with an 18-month follow-up. RR was estimated at month 12 in the overall population and baseline subgroups (combination with a conventional synthetic disease-modifying antirheumatic drug (csDMARD) or not, age, body mass index, methotrexate dose), using the Kaplan-Meier method. Patient compliance to TCZ-SC was described using the 5-item Compliance Questionnaire for Rheumatology (CQR5).Results: At inclusion 75% of the 285 analyzed patients were women, mean RA duration was 9 ± 9 years, previous RA treatments included biological agents (63%) and/or csDMARDs (94%), mean Disease Activity Score 28 joints-Erythrocyte Sedimentation Rate (DAS28-ESR) was 4.8 ± 1.2. TCZ-SC RR at month 12 was estimated to be 64% (95% CI 58%-69%) with no statistical differences between subgroups. Clinical results improved with TCZ-SC; the proportion of patients treated with combined glucocorticoids decreased from 49% to 22% at month 12. At each follow-up time, at least 80% of patients were high adherers to TCZ-SC (at least 80% of theoretical injections). Among the 286 patients with at least one TCZ-SC injection, 25 patients (9%) experienced serious adverse events related to TCZ-SC with no differences according to patient age.Conclusions: This real-world study corroborates the RR at month 12 previously shown in interventional studies on TCZ-SC. Our data suggest there are no differences according to patient's profile (age, BMI), methotrexate doses, and TCZ-SC use</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="regroupinstitution" xml:id="struct-184952" status="VALID">
          <idno type="ROR">https://ror.org/0246mbd04</idno>
          <orgName>Centre Hospitalier Sud Francilien - Centre Hospitalier d'Evry</orgName>
          <orgName type="acronym">CHSF</orgName>
          <desc>
            <address>
              <addrLine>40 Avenue Serge Dassault - 91100 Corbeil-Essonnes</addrLine>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300122" status="VALID">
          <idno type="IdRef">028228421</idno>
          <idno type="ROR">https://ror.org/01hq89f96</idno>
          <orgName>Centre Hospitalier Universitaire de Bordeaux</orgName>
          <orgName type="acronym">CHU Bordeaux</orgName>
          <desc>
            <address>
              <addrLine>12 rue Dubernat 33400 Talence</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.chu-bordeaux.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-257328" status="VALID">
          <idno type="IdRef">034137076</idno>
          <idno type="ROR">https://ror.org/041rhpw39</idno>
          <orgName>CHU de Grenoble-Alpes - Centre Hospitalier Universitaire CHU Grenoble</orgName>
          <orgName type="acronym">CHUGA</orgName>
          <desc>
            <address>
              <addrLine>CS 1021738043 Grenoble cedex 9</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-grenoble.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-425779" status="VALID">
          <idno type="IdRef">034424636</idno>
          <idno type="ISNI">0000000404718845</idno>
          <idno type="ROR">https://ror.org/02ppyfa04</idno>
          <idno type="Wikidata">Q2945741</idno>
          <orgName>Centre Hospitalier Régional Universitaire [CHU Lille]</orgName>
          <orgName type="acronym">CHRU Lille</orgName>
          <desc>
            <address>
              <addrLine>CHU/CHRU Lille - 2, avenue Oscar Lambret - 59037 Lille Cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.chru-lille.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300639" status="VALID">
          <idno type="IdRef">02661457X</idno>
          <orgName>Centre Hospitalier Régional d'Orléans</orgName>
          <orgName type="acronym">CHRO</orgName>
          <date type="start">2015-01-01</date>
          <date type="end">2023-10-11</date>
          <desc>
            <address>
              <addrLine>14 Avenue de l'Hôpital, 45100 Orléans</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.chr-orleans.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300113" status="VALID">
          <idno type="ROR">https://ror.org/05qsjq305</idno>
          <orgName>Centre Hospitalier Universitaire de Nice</orgName>
          <orgName type="acronym">CHU Nice</orgName>
          <desc>
            <address>
              <addrLine>30, Voie RomaineCS 51069 - 06001 Nice Cedex 1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-nice.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300535" status="VALID">
          <orgName>CHU Amiens-Picardie</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-493731" status="INCOMING">
          <orgName>Laboratoire Roche SAS [Boulogne Billancourt]</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-523983" status="INCOMING">
          <orgName>Chugai Pharma France, Paris La Défense</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-181247" status="VALID">
          <orgName>Centre de Rhumatologie [CHU Toulouse]</orgName>
          <desc>
            <address>
              <addrLine>1, place Baylac, BP 3028, 31024 Toulouse</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-toulouse.fr/-rhumatologie-centre-</ref>
          </desc>
          <listRelation>
            <relation active="#struct-1153142" type="direct"/>
            <relation active="#struct-300075" type="indirect"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-1075487" status="VALID">
          <idno type="ISNI">0000 0004 0634 7371</idno>
          <idno type="ROR">https://ror.org/03mg0pe18</idno>
          <orgName>Centre Hospitalier Dax - Côte d'Argent</orgName>
          <orgName type="acronym">CH Dax</orgName>
          <date type="start">1946-08-26</date>
          <desc>
            <address>
              <addrLine>1 Bd Yves du Manoir, 40100 Dax</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.ch-dax.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-556696" status="VALID">
          <idno type="IdRef">032808747</idno>
          <idno type="ROR">https://ror.org/04taf2z98</idno>
          <orgName>Centre hospitalier [Valenciennes, Nord]</orgName>
          <desc>
            <address>
              <addrLine>Valenciennes</addrLine>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-412239" status="VALID">
          <orgName>CHRU Brest - Service de Rhumatologie</orgName>
          <orgName type="acronym">CHU - BREST - Rhumato</orgName>
          <desc>
            <address>
              <addrLine>Hôpital de la Cavale Blanche, Boulevard Tanguy Prigent, 29200 Brest</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-356603" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-486351" status="VALID">
          <idno type="RNSR">201722606C</idno>
          <orgName>Lymphocytes B, Autoimmunité et Immunothérapies</orgName>
          <orgName type="acronym">LBAI</orgName>
          <date type="start">2022-01-01</date>
          <desc>
            <address>
              <addrLine>5 Foch - CHU Morvan - BP 824 - 29609 Brest - France</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://nouveau.univ-brest.fr/lbai/fr</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300314" type="direct"/>
            <relation name="U1227" active="#struct-303623" type="direct"/>
            <relation active="#struct-303644" type="direct"/>
            <relation active="#struct-1083366" type="indirect"/>
            <relation active="#struct-519898" type="direct"/>
          </listRelation>
        </org>
        <org type="regrouplaboratory" xml:id="struct-1153142" status="VALID">
          <orgName>Pôle Inflammation, infection, immunologie et loco-moteur [CHU Toulouse]</orgName>
          <orgName type="acronym">Pôle I3LM Toulouse</orgName>
          <desc>
            <address>
              <addrLine>Toulouse</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-300075" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300075" status="VALID">
          <orgName>Centre Hospitalier Universitaire de Toulouse</orgName>
          <orgName type="acronym">CHU Toulouse</orgName>
          <desc>
            <address>
              <addrLine>regroupe les hôpitaux  Purpan, Rangueil, Pierre-Paul Riquet, Larey, Paule de Viguier, Hôtel Dieu Saint-Jacques, La Grave, etc.</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chu-toulouse.fr</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-356603" status="VALID">
          <orgName>Centre Hospitalier Régional Universitaire de Brest</orgName>
          <orgName type="acronym">CHRU Brest</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-300314" status="VALID">
          <idno type="IdRef">291809022</idno>
          <idno type="ISNI">0000000121880893</idno>
          <idno type="ROR">https://ror.org/0372th171</idno>
          <orgName>Université de Brest</orgName>
          <orgName type="acronym">UBO EPE</orgName>
          <desc>
            <address>
              <addrLine>Université de Bretagne Occidentale - 3 Rue des Archives 29238, Brest</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.univ-brest.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="regrouplaboratory" xml:id="struct-303644" status="VALID">
          <orgName>LabEX IGO Immunothérapie Grand Ouest</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-1083366" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-1083366" status="VALID">
          <idno type="IdRef">258086599</idno>
          <idno type="ROR">https://ror.org/03gnr7b55</idno>
          <orgName>Nantes Université</orgName>
          <orgName type="acronym">Nantes Univ</orgName>
          <date type="start">2022-01-01</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="regrouplaboratory" xml:id="struct-519898" status="VALID">
          <idno type="RNSR">201722456P</idno>
          <orgName>Institut Brestois Santé Agro Matière</orgName>
          <orgName type="acronym">IBSAM</orgName>
          <date type="start">2017-10-12</date>
          <desc>
            <address>
              <addrLine>Université de Brest- UBO29238 Brest</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.univ-brest.fr/menu/recherche-innovation/Laboratoires/Axe+Sant%C3%A9-+Agro-+Mati%C3%A8re/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300314" type="direct"/>
          </listRelation>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>